Trial intelligence / Profile preview

Prophylactic erythropoietin in critically ill adults to prevent anemia

PACTR201803003169385Not yet recruiting

Sponsor
Asmaa Fawzy Amer
Start
Mar 2018
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Open-label trial of erythropoietin in anaemia (2 arms), sponsored by Asmaa Fawzy Amer. Primary endpoint: Incidence of anemia. Planned start Mar 2018; status: not yet recruiting.

02

Drugs

erythropoietin
03

Conditions

anaemia

Beyond the preview

Go deeper on PACTR201803003169385.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201803003169385.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call